News

VETS Stands Firm: Our Response to the FDA's Decision on MDMA-Assisted Therapy

Today, the Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Lykos Therapeutics in response to their application for approval of MDMA-assisted therapy.

The New York Times: Veterans and Lawmakers Lobby in Bipartisan Push for MDMA Therapy

More than a half century after federal regulators banned most psychedelic compounds, the Food and Drug Administration is nearing a decision on a novel treatment for post-traumatic stress disorder that pairs talk therapy with MDMA.

My 3rd Re-Birthday: 10 Integration Techniques I Still Practice Daily

Three years ago, on July 31st, 2021 I would sit up out of a bed in Mexico and my life would be changed in the most positive way. Thanks to VETS, I was able to receive a Foundational Healing Grant for psychedelic-assisted therapy treatment with ibogaine and 5MeO-DMT.

Press Release: VETS Applauds California Legislature for Expediting Passage of Bill to Resume Psychedelic Research

AB 2841, authored by Assemblymember Marie Waldron (R-Escondido) and co-authored by Senators Allen (D-Los Angeles) and Wiener (D-San Francisco), will allow the RAPC, a state advisory board in the California Attorney General’s Office, to meet in closed session to review and approve confidential scientific and medical research proposals involving cannabis, psychedelics, or the treatment of substance use disorders.

The Economist: Mexico has become a testing ground for psychedelic therapies

Many of those turning to psychedelics are former soldiers. Martín Polanco, a doctor who runs The Mission Within near Tijuana, says he has treated 1,000 veterans with ibogaine since 2016 (researchers do not classify ibogaine as a psychedelic, but it provides some of the same effects).